| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | 0.0087 | 0.8 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0084 | 0.8 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.0082 | 0.8 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | 0.0085 | 0.8 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | -0.0085 | 0.8 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | -0.0077 | 0.8 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.0071 | 0.8 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.0072 | 0.8 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.0076 | 0.8 |